Your browser doesn't support javascript.
loading
Mostrar: 20 | 50 | 100
Resultados 1 - 3 de 3
Filtrar
Mais filtros











Intervalo de ano de publicação
1.
Acta Cir Bras ; 33(6): 533-541, 2018 Jun.
Artigo em Inglês | MEDLINE | ID: mdl-30020315

RESUMO

PURPOSE: To investigate the specific molecular mechanisms and effects of curcumin derivative J147 on diabetic peripheral neuropathy (DPN). METHODS: We constructed streptozotocin (STZ)-induced DPN rat models to detected mechanical withdrawal threshold (MWT) in vivo using Von Frey filaments. In vitro, we measured cell viability and apoptosis, adenosine 5'-monophosphate-activated protein kinase (AMPK) and transient receptor potential A1 (TRPA1) expression using MTT, flow cytometry, qRT-PCR and western blot. Then, TRPA1 expression level and calcium reaction level were assessed in agonist AICAR treated RSC96cells. RESULTS: The results showed that J147reduced MWT in vivo, increased the mRNA and protein level of AMPK, reduced TRPA1 expression and calcium reaction level in AITCR treated RSC96 cells, and had no obvious effect on cell viability and apoptosis. Besides, AMPK negative regulated TRPA1 expression in RSC96 cells. CONCLUSIONS: J147 could ameliorate DPN via negative regulation AMPK on TRPA1 in vivo and in vitro. A curcumin derivative J147might be a new therapeutic potential for the treatment of DPN.


Assuntos
Proteínas Quinases Ativadas por AMP/efeitos dos fármacos , Curcumina/análogos & derivados , Curcumina/farmacologia , Neuropatias Diabéticas/tratamento farmacológico , Canal de Cátion TRPA1/efeitos dos fármacos , Proteínas Quinases Ativadas por AMP/análise , Animais , Apoptose/efeitos dos fármacos , Western Blotting , Cálcio/análise , Sobrevivência Celular/efeitos dos fármacos , Células Cultivadas , Diabetes Mellitus Experimental/complicações , Diabetes Mellitus Experimental/metabolismo , Neuropatias Diabéticas/metabolismo , Masculino , Microscopia de Fluorescência , Reação em Cadeia da Polimerase em Tempo Real , Reprodutibilidade dos Testes , Estreptozocina , Canal de Cátion TRPA1/análise , Fatores de Tempo
2.
Acta cir. bras. ; 33(6): 533-541, jun. 2018. graf
Artigo em Inglês | VETINDEX | ID: vti-734724

RESUMO

Purpose: To investigate the specific molecular mechanisms and effects of curcumin derivative J147 on diabetic peripheral neuropathy (DPN). Methods: We constructed streptozotocin (STZ)-induced DPN rat models to detected mechanical withdrawal threshold (MWT) in vivo using Von Frey filaments. In vitro, we measured cell viability and apoptosis, adenosine 5-monophosphate-activated protein kinase (AMPK) and transient receptor potential A1 (TRPA1) expression using MTT, flow cytometry, qRT-PCR and western blot. Then, TRPA1 expression level and calcium reaction level were assessed in agonist AICAR treated RSC96cells. Results: The results showed that J147reduced MWT in vivo, increased the mRNA and protein level of AMPK, reduced TRPA1 expression and calcium reaction level in AITCR treated RSC96 cells, and had no obvious effect on cell viability and apoptosis. Besides, AMPK negative regulated TRPA1 expression in RSC96 cells. Conclusions: J147 could ameliorate DPN via negative regulation AMPK on TRPA1 in vivo and in vitro. A curcumin derivative J147might be a new therapeutic potential for the treatment of DPN.(AU)


Assuntos
Animais , Masculino , Adulto , Ratos , Curcumina/análogos & derivados , Curcumina/farmacologia , Curcumina/uso terapêutico , Doenças do Sistema Nervoso Periférico/tratamento farmacológico , Proteínas Quinases , Canais de Potencial de Receptor Transitório , Complicações do Diabetes/induzido quimicamente , Complicações do Diabetes/tratamento farmacológico
3.
Acta cir. bras ; Acta cir. bras;33(6): 533-541, June 2018. graf
Artigo em Inglês | LILACS | ID: biblio-949351

RESUMO

Abstract Purpose: To investigate the specific molecular mechanisms and effects of curcumin derivative J147 on diabetic peripheral neuropathy (DPN). Methods: We constructed streptozotocin (STZ)-induced DPN rat models to detected mechanical withdrawal threshold (MWT) in vivo using Von Frey filaments. In vitro, we measured cell viability and apoptosis, adenosine 5'-monophosphate-activated protein kinase (AMPK) and transient receptor potential A1 (TRPA1) expression using MTT, flow cytometry, qRT-PCR and western blot. Then, TRPA1 expression level and calcium reaction level were assessed in agonist AICAR treated RSC96cells. Results: The results showed that J147reduced MWT in vivo, increased the mRNA and protein level of AMPK, reduced TRPA1 expression and calcium reaction level in AITCR treated RSC96 cells, and had no obvious effect on cell viability and apoptosis. Besides, AMPK negative regulated TRPA1 expression in RSC96 cells. Conclusions: J147 could ameliorate DPN via negative regulation AMPK on TRPA1 in vivo and in vitro. A curcumin derivative J147might be a new therapeutic potential for the treatment of DPN.


Assuntos
Animais , Masculino , Curcumina/análogos & derivados , Curcumina/farmacologia , Neuropatias Diabéticas/tratamento farmacológico , Proteínas Quinases Ativadas por AMP/efeitos dos fármacos , Canal de Cátion TRPA1/efeitos dos fármacos , Fatores de Tempo , Sobrevivência Celular/efeitos dos fármacos , Células Cultivadas , Western Blotting , Cálcio/análise , Reprodutibilidade dos Testes , Apoptose/efeitos dos fármacos , Estreptozocina , Diabetes Mellitus Experimental/complicações , Diabetes Mellitus Experimental/metabolismo , Neuropatias Diabéticas/metabolismo , Proteínas Quinases Ativadas por AMP/análise , Reação em Cadeia da Polimerase em Tempo Real , Canal de Cátion TRPA1/análise , Microscopia de Fluorescência
SELEÇÃO DE REFERÊNCIAS
DETALHE DA PESQUISA